MEDTRONIC PLC DL-,0001 chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 23.08
Dividend & Yield2.59€ (3.61%)
Beta 0.74
Market capitalization 95.94B
Operating cash flow 6.29B
ESG Scores 22.7

Company description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio2.14
Working Capital0.26
Return On Equity0.07
Debt To Equity0.51
Fixed Asset Ratio0.21
Fixed Interest Cover5.9

Financial data

Financial Statements

Cashflow Statement 2019-04-26 2020-04-24 2021-04-30 2022-04-29
Change To Liabilities 399M -44M 531M 213M
Total Cashflows From Investing Activities -774M -3.2B -2.87B -1.66B
Net Borrowings -867M -559M -570M -1M
Total Cash From Financing Activities -5.43B -4.2B -4.14B -5.34B
Change To Operating Activities -624M -609M -549M -65M
Issuance Of Stock 992M 662M 474M 429M
Net Income 4.63B 4.79B 3.61B 5.04B
Change In Cash 724M -253M -547M 121M
Effect Of Exchange Rate -78M -86M 215M -231M
Total Cash From Operating Activities 7.01B 7.23B 6.24B 7.35B
Depreciation 2.66B 2.66B 2.7B 2.71B
Change To Account Receivables -581M 1.29B -761M -477M
Other Cashflows From Financing Activities 14M -81M -268M 163M
Change To Netincome 797M -279M 633M 489M
Capital Expenditures -1.13B -1.21B -1.35B -1.37B

Income Statement 2019-04-26 2020-04-24 2021-04-30 2022-04-29
Research Development 2.33B 2.33B 2.49B 2.75B
Income Before Tax 5.2B 4.05B 3.9B 5.52B
Net Income 4.63B 4.79B 3.61B 5.04B
Selling General Administrative 10.27B 9.88B 9.87B 10.03B
Gross Profit 21.49B 19.64B 19.76B 21.66B
Ebit 6.71B 5.16B 5.51B 7.02B
Operating Income 6.71B 5.16B 5.51B 7.02B
Interest Expense -1.44B -1.09B -925M -553M
Income Tax Expense 547M -751M 265M 456M
Total Revenue 30.56B 28.91B 30.12B 31.69B
Cost Of Revenue 9.06B 9.27B 10.36B 10.03B
Total Other Income ExpenseNet -1.51B -1.11B -1.62B -1.5B
Net Income From Continuing Ops 4.65B 4.81B 3.63B 5.06B
Net Income Applicable To Common Shares 4.63B 4.79B 3.61B 5.04B

Balance Sheet Statement 2019-04-26 2020-04-24 2021-04-30 2022-04-29
Total Liabilities 39.48B 39.82B 41.48B 38.26B
Total Stockholder Equity 50.09B 50.74B 51.43B 52.55B
Other Current Liabilities 1.77B 867M 990M 1.16B
Total Assets 89.69B 90.69B 93.08B 90.98B
Common Stock
Other Current Assets 2.53B 2.21B 1.96B 2.32B
Retained Earnings 16.1B 28.13B 28.59B 30.25B
Treasury Stock -2.71B -3.56B -3.48B -2.27B
Cash 4.39B 4.14B 3.59B 3.71B
Total Current Liabilities 6.99B 10.37B 8.51B 12.39B
Other Stockholder Equity -2.71B -3.56B -3.48B -2.27B
Property, Plant, and Equipment 4.04B 5.75B 6.22B 6.27B
Total Current Assets 24.08B 22.03B 22.55B 23.06B
Net Tangible Assets -11.06B -8.17B -8.27B -3.55B
Net Receivables 7.95B 4.64B 5.46B 5.55B
Accounts Payable 1.95B 2B 2.11B 2.28B


Insider Transactions

Here are the insider transactions of stock shares related to MEDTRONIC PLC DL-,0001:

Filer Name Transaction Text Ownership Date Filer Relation Shares
TEN HOEDT ROBSale at price 81.54 per share.D2022-10-14Officer2.4k
TEN HOEDT ROBConversion of Exercise of derivative security at price 41.60 per share.D2022-10-14Officer2.4k
FONG IVAN KStock Award(Grant) at price 0.00 per share.D2022-08-01General Counsel6.94k
SURFACE CAROL AStock Award(Grant) at price 0.00 per share.D2022-08-01Officer5.16k
PARKHILL KAREN LStock Award(Grant) at price 0.00 per share.D2022-08-01Chief Financial Officer10.74k
SMITH GREGORY LStock Award(Grant) at price 0.00 per share.D2022-08-01Officer5.59k
MARTHA GEOFFREY SStock Award(Grant) at price 0.00 per share.D2022-08-01Chief Executive Officer28.47k
TEN HOEDT ROBStock Award(Grant) at price 0.00 per share.D2022-08-01Officer7.31k
KIRK JENNIFER MStock Award(Grant) at price 0.00 per share.D2022-08-01Officer2.36k
WHITE ROBERT JOHNStock Award(Grant) at price 0.00 per share.D2022-08-01Officer8.6k
WALL BRETT AStock Award(Grant) at price 0.00 per share.D2022-08-01Officer7.52k
SALMON SEANStock Award(Grant) at price 0.00 per share.D2022-08-01Officer8.6k
ANDERSON RICHARD HStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
POWELL KENDALL JStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
O LEARY DENISE MStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
HOGAN RANDALL J IIIStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
DONNELLY SCOTT CStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
ARNOLD CRAIGStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
LOFTON KEVIN EStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
NABEL ELIZABETH GStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
GOLDSMITH ANDREA JOStock Award(Grant) at price 0.00 per share.D2022-05-02Director1.7k
PARKHILL KAREN LSale at price 110.00 per share.D2022-03-18Chief Financial Officer682
SURFACE CAROL ASale at price 105.30 per share.D2022-03-11Officer6k
FONG IVAN KStock Award(Grant) at price 0.00 per share.D2022-02-01General Counsel30.37k
WHITE ROBERT JOHNSale at price 102.04 per share.D2021-12-23Officer7.22k
ANDERSON RICHARD HPurchase at price 103.26 per share.D2021-12-16Director5.01k
PARKHILL KAREN LStock Gift at price 0.00 per share.I2021-12-06Chief Financial Officer49.86k
PARKHILL KAREN LSale at price 110.00 per share.D2021-12-06Chief Financial Officer682
TEN HOEDT ROBStock Award(Grant) at price 0.00 per share.D2021-11-01Officer832
PARKHILL KAREN LStock Gift at price 0.00 per share.D2021-10-08Chief Financial Officer49.86k
LERMAN BRADLEY ESale at price 126.58 per share.D2021-09-30General Counsel49.15k
LERMAN BRADLEY EConversion of Exercise of derivative security at price 78.00 per share.D2021-09-30General Counsel49.15k
LERMAN BRADLEY ESale at price 134.17 per share.D2021-08-31General Counsel50.77k
LERMAN BRADLEY EConversion of Exercise of derivative security at price 74.84 per share.D2021-08-31General Counsel50.77k
MARTHA GEOFFREY SSale at price 132.67 per share.D2021-08-25Chief Executive Officer11.58k
MARTHA GEOFFREY SConversion of Exercise of derivative security at price 55.32 - 62.76 per share.D2021-08-25Chief Executive Officer11.58k
SALMON SEANSale at price 134.08 - 134.09 per share.D2021-08-25Officer28.42k
SALMON SEANConversion of Exercise of derivative security at price 38.20 - 38.81 per share.D2021-08-25Officer28.42k
SURFACE CAROL AStock Award(Grant) at price 0.00 per share.D2021-08-02Officer3.66k
PARKHILL KAREN LStock Award(Grant) at price 0.00 per share.D2021-08-02Chief Financial Officer7.16k
KUNTZ RICHARD EStock Award(Grant) at price 0.00 per share.D2021-08-02Officer5.03k
LERMAN BRADLEY EStock Award(Grant) at price 0.00 per share.D2021-08-02General Counsel6.02k
LERMAN BRADLEY ESale at price 131.52 per share.D2021-08-02General Counsel4k
MARTHA GEOFFREY SStock Award(Grant) at price 0.00 per share.D2021-08-02Chief Executive Officer19.05k
TEN HOEDT ROBStock Award(Grant) at price 0.00 per share.D2021-08-02Officer4.42k
KIRK JENNIFER MStock Award(Grant) at price 0.00 per share.D2021-08-02Officer1.14k
WHITE ROBERT JOHNStock Award(Grant) at price 0.00 per share.D2021-08-02Officer6.09k
LIDDICOAT JOHN R.Stock Award(Grant) at price 0.00 per share.D2021-08-02Officer3.35k
WALL BRETT AStock Award(Grant) at price 0.00 per share.D2021-08-02Officer5.33k
SALMON SEANStock Award(Grant) at price 0.00 per share.D2021-08-02Officer5.49k
MARTHA GEOFFREY SSale at price 125.29 per share.D2021-06-28Chief Executive Officer11.5k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to MEDTRONIC PLC DL-,0001. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on MEDTRONIC PLC DL-,0001

Here is the result of two systematic investment strategies applied to MEDTRONIC PLC DL-,0001. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on MEDTRONIC PLC DL-,0001

The following chart shows the equity curve of the two systematic investment strategies applied to MEDTRONIC PLC DL-,0001:

MEDTRONIC PLC DL-,0001 automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 15.32% on the backtest period.

Performance at glance

Performance

15.32 %

Latent gain

234.49 €

Invested capital

1530.96 €

Annualized return

3.72 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on MEDTRONIC PLC DL-,0001

This is the result of two momentum investment strategies applied to MEDTRONIC PLC DL-,0001. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on MEDTRONIC PLC DL-,0001

The following chart shows all the entries opened by the momentum investment system on MEDTRONIC PLC DL-,0001:

MEDTRONIC PLC DL-,0001 momentum entries
  • The first momentum investment strategy would give 25.84% of return on MEDTRONIC PLC DL-,0001. That represents 1215.53€ of latent gain with 4703.92€ of employed capital.
  • The second momentum investment strategy would give 18.15% of return on MEDTRONIC PLC DL-,0001. That represents 701.79€ of latent gain with 3867.61€ of employed capital.
Performance at glance (1Q Momentum)

Performance

25.84 %

Latent gain

1215.53 €

Invested capital

4703.92 €

Annualized return

12.03 %
Performance at glance (2Q Momentum)

Performance

18.15 %

Latent gain

701.79 €

Invested capital

3867.61 €

Annualized return

4.99 %

Momentum equity curve on MEDTRONIC PLC DL-,0001

The following chart shows the equity curve of the two momentum strategies applied to MEDTRONIC PLC DL-,0001:

MEDTRONIC PLC DL-,0001 momentum equity

Note: the dividends potentially given by MEDTRONIC PLC DL-,0001 are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MEDTRONIC PLC DL-,0001

The following chart shows the employed capital evolution of the two momentum strategies on MEDTRONIC PLC DL-,0001 since the beginning:

MEDTRONIC PLC DL-,0001

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250€, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000€.


Buy the dip strategy result on MEDTRONIC PLC DL-,0001

Buy the dip entry openings on MEDTRONIC PLC DL-,0001

MEDTRONIC PLC DL-,0001

The performance achieved by the robo-advisor on MEDTRONIC PLC DL-,0001 is 25.51%. That represents 63.33$ of latent gain with 248.22€ of employed capital. The following chart shows MEDTRONIC PLC DL-,0001 stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of MEDTRONIC PLC DL-,0001, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

25.51 %

Latent gain

63.33 €

Invested capital

248.22 €

Annualized return

12.03 %

Equity curve of the strategy applied to MEDTRONIC PLC DL-,0001

The following chart shows the result of the investment strategy applied to MEDTRONIC PLC DL-,0001:

MEDTRONIC PLC DL-,0001

Note: the dividends potentially given by MEDTRONIC PLC DL-,0001 are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MEDTRONIC PLC DL-,0001

The following chart shows the employed capital evolution since the beginning of the investment strategy on MEDTRONIC PLC DL-,0001:

MEDTRONIC PLC DL-,0001

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on MEDTRONIC PLC DL-,0001

In this section, I will compare the three previous investment strategies applied to MEDTRONIC PLC DL-,0001.

Equity curve comparison on MEDTRONIC PLC DL-,0001

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

MEDTRONIC PLC DL-,0001 investment strategy comparison

Employed capital comparison on MEDTRONIC PLC DL-,0001

MEDTRONIC PLC DL-,0001 investment comparison

Performance comparison on MEDTRONIC PLC DL-,0001

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 15.32% 234.49€ 1530.96€ 3.72%
Momentum 1 quarter 25.84% 1215.53€ 4703.92€ 6.66%
Momentum 2 quarters 18.15% 701.79€ 3867.61€ 4.99%
Non-directional 25.51% 63.33€ 248.22€ 12.03%
Annualized return comparison

Automatic investment

3.72 %

Momentum 1Q

4.99 %

Momentum 2Q

4.99 %

Non-directional

12.03 %

Correlated stocks

Here are the most positively and negatively correlated stocks with MEDTRONIC PLC DL-,0001:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between MEDTRONIC PLC DL-,0001 and the other stocks. There may be false positives or some missing correlated stocks. If the price of MEDTRONIC PLC DL-,0001 does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name MEDTRONIC PLC DL-,0001
Country Ireland
City Dublin
Address 20 On Hatch
Phone 353 1 438 1700
Website www.medtronic.com
FullTime employees 95000
Industry Medical Devices
Sector Healthcare
Exchange XETRA
Ticker 2M6.XETRA
Market www.xetra.com

MEDTRONIC PLC DL-,0001 ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 2.4
Peer Environment Performance 2.2440350877193
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing yes

Social scores

Social ESG Factors Scores
Social Score 12.6
Peer Social Performance 12.085087719298
Social Percentile unknown
Highest Controversy 3
Peer Highest Controversy Performance 1.9310344827586
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic no
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Customer Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 7.6
Peer Governance Performance 7.7398245614035
Governance Percentile unknown

ESG at glance
Total ESG Scores: 22.7
Environment Score: 2.4
Social Score: 12.6
Governance Score: 7.6

ESG Performance: AVG_PERF

Peer Group: Healthcare

Peer Esg Score Performance: 22.091551724138

Rating Year: 2022

Rating Month: 8

Max Age: 86400

Percentile: 35